Delivery Order SPE2DB22D1017-SPE2DB25FE9SX

Award Date 11/21/24
Potential Completion Date 11/22/24
Potential Value $5.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $19,357.64 firm fixed price delivery order is for the supply of 4,566,660,824 Valsartan-HCTZ 160-12.5 mg tablets, which are used to treat high blood pressure. This contract is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Valsartan-HCTZ 320-25 mg tablets. The $6,361.52 firm fixed-price delivery order contract has an ultimate completion date of October 21, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a comprehensive vehicle for...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $17,252.52, is for the delivery of valsartan-HCTZ 320-25 mg tablets. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical division. This IDC serves as a primary vehicle for providing a...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Valsartan-HCTZ 320-25 mg tablets. The $3,797.39 firm fixed-price delivery order has an ultimate completion date of October 22, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,638.30 firm fixed-price delivery order is for the supply of Valsartan-HCTZ 320-25 mg tablets. The contract has an ultimate completion date of June 23, 2025 and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,055.94 Delivery Order contract is for the supply of Valsartan-HCTZ 320-25 mg tablets, a cardiovascular medication. The contract is a Firm Fixed Price agreement with a completion date of December 13, 2024. It is not designated as a set-aside contract. This Delivery Order is likely part of a larger Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,394.24 firm fixed-price delivery order is for the supply of 4566198567 - Valsartan-HCTZ 320-25 mg tablets, with an ultimate completion date of October 25, 2024. The award is a part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which...
This federal contract award, valued at $3,250.37, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Valsartan-HCTZ 160-12.5 mg tablets in 90-count packages. The award is a delivery order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical. This IDC serves as a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,054.46 fixed-price delivery order is for the supply of 4,566,382,899 units of the drug Valsartan-HCTZ 320-25 mg tablets. The award is a task order under AmerisourceBergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive...
This is a federal contract award issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of valsartan-HCTZ 320-25 mg tablets in 90-count packages, with a total ceiling value of $1,742.24 and a period of performance through December 9, 2024. The contract is a delivery order under an existing Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen...
  • SPE2DB22D1017
    Indefinite Delivery Contract
  • SPE2DB22D1017-SPE2DB25FE9SX
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,222.53 firm fixed-price delivery order is for the supply of 90-count bottles of the blood pressure medication Valsartan-HCTZ 320-25 mg tablets.

The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between AmerisourceBergen and the DLA Troop Support Medical division, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This IDC, which runs through November 2026, covers critical medical commodities across multiple therapeutic areas.

The contract award does not have a set-aside designation, indicating open competition. AmerisourceBergen, as the prime contractor, will be responsible for delivering the Valsartan-HCTZ tablets to the specified place of performance in Conshohocken, Pennsylvania by the ultimate completion date of November 22, 2024.

Generated 5/20/25, 1:47 PM